The current stock price likely implies Botox declines, but we think the franchise can maintain healthy growth as a result of expansion of the market and limited price competition. Firms Likely to Have ...

With CGRP drugs on the rise in the preventive migraine market, old stalwarts like Allergan's Botox are feeling the pinch from the new competition. But a new survey says neurologists may not be so ...

CHICAGO (Reuters) - Allergan Inc said on Thursday that its popular Botox facial wrinkle-smoother worked as a treatment for adults suffering from chronic migraines, according to late-stage clinical ...

Allergan Aesthetics receives European approval for Boey, the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients: ...

Allergan is working to close a deal to sell itself to AbbVie, which will count on Botox for growth. (Allergan) () An Allergan subsidiary is attributing a 17% slide in pretax profits last year to ...

IRVINE, Calif., Nov. 16, 2020 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is celebrating its second annual BOTOX® Cosmetic Day on Wednesday, November 18, 2020. The event is ...

Jan 4 (Reuters) - A federal judge on Wednesday said Botox maker AbbVie's ABBV.N Allergan unit can move ahead with its lawsuit accusing Revance Therapeutics RVNC.O of taking its confidential data to ...

A happy coincidence put data in front of Allergan’s aesthetics marketing team that proved Botox appointments spiked around the holidays. The research showed that November 20 is the busiest day of the ...

Concerns about eventual competition for Allergan Inc.’s cash cow Botox don’t seem to be weighing on the Irvine drug maker’s shares. For now, investors seem content with the company’s strong ...

(Reuters) - Botox maker AbbVie Inc's Allergan unit has accused Revance Therapeutics Inc in a federal lawsuit of poaching key employees in a "desperate" effort to compete in the market for anti-wrinkle ...